What is Eikon Therapeutics, Inc. 's accounts payable?

Eikon Therapeutics, Inc. (EIKN) reported accounts payable of $6.01M in Q1 2026.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

RepligenRGEN

$34.66M+28.7%

Cabot CorporationCBT

$598M+3.6%

Travel + LeisureTNL

$63M-6.0%

UnifirstUNF

$92.09M+2.8%

HES

Hess MidstreamHESM

$22.8M-42.6%

Warrior Met CoalHCC

$72.22M+26.2%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's accounts payable?: Eikon Therapeutics, Inc. (EIKN) reported accounts payable of $6.01M in Q1 2026.
What does accounts payable mean?: Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.